• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Jushi Reports Q2 2026 Financial Results

BOCA RATON – Jushi Holdings Inc. released its second-quarter 2026 financial results, posting revenue of $71.3 million, a 10% year-over-year gain, with growth spread across both the retail and wholesale channels. The wholesale segment set ...

Vireo Growth Sets Stage for Planet 13 Acquisition

MINNEAPOLIS - LAS VEGAS – Vireo Growth Inc. and Planet 13 Holdings Inc. have agreed to combine operations under a definitive merger agreement. The move brings together two multi-state Cannabis operators and expands retail reach ...

Delaware Moves to Regulate THC-Infused Beverages

DOVER – Delaware's Senate Banking, Business, Insurance & Technology Committee advanced House Bill 373, sending the measure to the Senate Finance Committee and bringing it a step closer to a full Senate vote. The action ...

Glass House Brands Triggers Warrant Acceleration

LONG BEACH – Glass House Brands Inc., a major player in California Cannabis production and retail, has told holders of warrants issued in two earlier financing rounds that their right to convert those securities into ...

Otsuka Completes $1.23B Buyout of Transcend Therapeutics

PRINCETON – Otsuka America, the U.S. subsidiary of Otsuka Pharmaceutical Co., Ltd., announced that it has completed its acquisition of Transcend Therapeutics, a New York biotechnology company developing rapid-acting treatments for neuropsychiatric disease. First disclosed ...

Glass House Brands Applies for NYSE Uplisting

LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among ...

Optimi Ships Psilocybin to the UK for Phase 2 Trial

VANCOUVER – Optimi Health Corp. announced it has completed its first export of naturally derived psilocybin to the United Kingdom, with the material earmarked for a planned Phase 2 clinical trial whose partner and therapeutic ...

Subscribe To Our Newsletter

Go to Top